This Article Full Text Full Text (PDF) All Versions of this Article: 93/2/114    most recent 01.RES.0000081594.21764.44v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Silvestre, J.-S. Articles by Lévy, B. I. Search for Related Content PubMed PubMed Citation Articles by Silvestre, J.-S. Articles by Lévy, B. I. Related Collections Angiogenesis Cerebral Lacunes Gene therapy

(Circulation Research. 2003;93:114.)
© 2003 American Heart Association, Inc.

Integrative Physiology

Vascular Endothelial Growth Factor-B Promotes In Vivo Angiogenesis

Jean-Sébastien Silvestre, Radia Tamarat, Teni G. Ebrahimian, Aude Le-Roux, Michel Clergue, Florence Emmanuel, Micheline Duriez, Bertrand Schwartz, Didier Branellec, Bernard I. Lévy

From INSERM U541 (J.-S.S., R.T., T.G.E., M.C., M.D., B.I.L.), Hôpital Lariboisière, Paris, France, and Gencell SA (A.L.-R., F.E., B.S., D.B.), Vitry Sur Seine, France.

Correspondence to Bernard I. Levy, U541-INSERM, Hôpital Lariboisière, 41 Bd de la Chapelle, 75475 Paris cedex 10, France. E-mail levy{at}infobiogen.fr

Vascular endothelial growth factors (VEGFs) and their receptors have emerged as central regulators of the angiogenic process. However, involvement of VEGF-B, one of these factors, in angiogenesis remains obscure. Mice received subcutaneous injection of Matrigel alone or Matrigel with human recombinant protein rhVEGF-B₁₆₇ or with rhVEGF-A₁₆₅. After 14 days, cell ingrowth in the Matrigel plug was increased by 2.0- and 2.5-fold in rhVEGF-B₁₆₇–treated and rhVEGF-A₁₆₅–treated mice, respectively (P<0.01), in association with a raise in phospho-Akt/Akt (1.8-fold, P<0.01) and endothelial NO synthase (eNOS) (1.80- and 1.60-fold, respectively; P<0.05) protein levels measured by Western blot. VEGF-B–induced cell ingrowth was impaired by treatment with NOS inhibitor (N^G-nitro-L-arginine methyl ester; L-NAME, 10 mg/kg per day). Treatment with neutralizing antibody directed against the VEGF-B receptor VEGF-R1 (anti-VEGFR1, 10 µg) completely abrogated VEGF-B–related effects. Proangiogenic effect of VEGF-B was confirmed in a mouse model of surgically induced hindlimb ischemia. Plasmids containing human form of VEGF-A (phVEGF-A₁₆₅) or VEGF-B (phVEGF-B₁₆₇ or phVEGF-B₁₈₆) were administered by in vivo electrotransfer. Angiographic score at day 28 showed significant improvement in ischemic/nonischemic leg ratio by 1.4- and 1.5-fold in mice treated with phVEGF-B₁₆₇ and phVEGF-B₁₈₆, respectively (P<0.05). Laser Doppler perfusion data also evidenced a 1.5-fold increase in phVEGF-B₁₆₇–treated and phVEGF-B₁₈₆–treated mice (P<0.05). Such an effect was associated with an upregulation of phospho-Akt/Akt and eNOS protein levels in the ischemic legs and was hampered by treatment with anti-VEGFR1. This study demonstrates for the first time that VEGF-B, in part through its receptor VEGF-R1, promotes angiogenesis in association with an activation of Akt and eNOS-related pathways.

Key Words: vascular endothelial growth factor-B • angiogenesis • ischemia • endothelial nitric oxide

This article has been cited by other articles:

				F. Zhang, Z. Tang, X. Hou, J. Lennartsson, Y. Li, A. W. Koch, P. Scotney, C. Lee, P. Arjunan, L. Dong, et al. VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis PNAS, April 14, 2009; 106(15): 6152 - 6157. [Abstract] [Full Text] [PDF]

				C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet Role and Therapeutic Potential of VEGF in the Nervous System Physiol Rev, April 1, 2009; 89(2): 607 - 648. [Abstract] [Full Text] [PDF]

				J. E. Lahteenvuo, M. T. Lahteenvuo, A. Kivela, C. Rosenlew, A. Falkevall, J. Klar, T. Heikura, T. T. Rissanen, E. Vahakangas, P. Korpisalo, et al. Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1- and Neuropilin Receptor-1-Dependent Mechanisms Circulation, February 17, 2009; 119(6): 845 - 856. [Abstract] [Full Text] [PDF]

				W.-P. T Ruifrok, R. A de Boer, A. Iwakura, M. Silver, K. Kusano, R. A Tio, and D. W Losordo Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia Vascular Medicine, February 1, 2009; 14(1): 29 - 36. [Abstract] [PDF]

				X. Li, M. Tjwa, I. Van Hove, B. Enholm, E. Neven, K. Paavonen, M. Jeltsch, T. D. Juan, R. E. Sievers, E. Chorianopoulos, et al. Reevaluation of the Role of VEGF-B Suggests a Restricted Role in the Revascularization of the Ischemic Myocardium Arterioscler. Thromb. Vasc. Biol., September 1, 2008; 28(9): 1614 - 1620. [Abstract] [Full Text] [PDF]

				J. Dai and A.B.M. Rabie VEGF: an Essential Mediator of Both Angiogenesis and Endochondral Ossification Journal of Dental Research, October 1, 2007; 86(10): 937 - 950. [Abstract] [Full Text] [PDF]

				W.-J. Cai, M.-J. Wang, P. K. Moore, H.-M. Jin, T. Yao, and Y.-C. Zhu The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation Cardiovasc Res, October 1, 2007; 76(1): 29 - 40. [Abstract] [Full Text] [PDF]

				S. Arab, I. E. Konstantinov, C. Boscarino, E. Cukerman, A. Mori, J. Li, P. P. Liu, A. N. Redington, and J. G. Coles Early gene expression profiles during intraoperative myocardial ischemia-reperfusion in cardiac surgery J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 74 - 81. [Abstract] [Full Text] [PDF]

				S. Yla-Herttuala, T. T. Rissanen, I. Vajanto, and J. Hartikainen Vascular Endothelial Growth Factors: Biology and Current Status of Clinical Applications in Cardiovascular Medicine J. Am. Coll. Cardiol., March 13, 2007; 49(10): 1015 - 1026. [Abstract] [Full Text] [PDF]

				Y. Wu, Z. Zhong, J. Huber, R. Bassi, B. Finnerty, E. Corcoran, H. Li, E. Navarro, P. Balderes, X. Jimenez, et al. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer. Clin. Cancer Res., November 1, 2006; 12(21): 6573 - 6584. [Abstract] [Full Text] [PDF]

				T. Shibuya, K. Watanabe, H. Yamashita, K. Shimizu, H. Miyashita, M. Abe, T. Moriya, H. Ohta, H. Sonoda, T. Shimosegawa, et al. Isolation and Characterization of Vasohibin-2 as a Homologue of VEGF-Inducible Endothelium-Derived Angiogenesis Inhibitor Vasohibin Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1051 - 1057. [Abstract] [Full Text] [PDF]

				R. J. Tomanek, Y. Ishii, J. S. Holifield, C. L. Sjogren, H. K. Hansen, and T. Mikawa VEGF Family Members Regulate Myocardial Tubulogenesis and Coronary Artery Formation in the Embryo Circ. Res., April 14, 2006; 98(7): 947 - 953. [Abstract] [Full Text] [PDF]

				L. Waeckel, J. Bignon, J.-M. Liu, D. Markovits, T. G. Ebrahimian, J. Vilar, B. Mees, O. Blanc-Brude, V. Barateau, S. Le ricousse-Roussanne, et al. Tetrapeptide AcSDKP Induces Postischemic Neovascularization Through Monocyte Chemoattractant Protein-1 Signaling Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 773 - 779. [Abstract] [Full Text] [PDF]

				C. Xing, B. E.K. Klein, R. Klein, G. Jun, K. E. Lee, and S. K. Iyengar Genome-Wide Linkage Study of Retinal Vessel Diameters in the Beaver Dam Eye Study Hypertension, April 1, 2006; 47(4): 797 - 802. [Abstract] [Full Text] [PDF]

				A. K. Malik, M. E. Baldwin, F. Peale, G. Fuh, W.-C. Liang, H. Lowman, G. Meng, N. Ferrara, and H.-P. Gerber Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice Blood, January 15, 2006; 107(2): 550 - 557. [Abstract] [Full Text] [PDF]

				A. W. Mould, S. A. Greco, M. M. Cahill, I. D. Tonks, D. Bellomo, C. Patterson, A. Zournazi, A. Nash, P. Scotney, N. K. Hayward, et al. Transgenic Overexpression of Vascular Endothelial Growth Factor-B Isoforms by Endothelial Cells Potentiates Postnatal Vessel Growth In Vivo and In Vitro Circ. Res., September 16, 2005; 97(6): e60 - e70. [Abstract] [Full Text] [PDF]

				R. Krebs, J. M. Tikkanen, A. I. Nykanen, J. Wood, M. Jeltsch, S. Yla-Herttuala, P. K. Koskinen, and K. B. Lemstrom Dual Role of Vascular Endothelial Growth Factor in Experimental Obliterative Bronchiolitis Am. J. Respir. Crit. Care Med., June 15, 2005; 171(12): 1421 - 1429. [Abstract] [Full Text] [PDF]

				P. Madeddu Therapeutic angiogenesis and vasculogenesis for tissue regeneration Exp Physiol, May 1, 2005; 90(3): 315 - 326. [Abstract] [Full Text] [PDF]

				T. Tammela, B. Enholm, K. Alitalo, and K. Paavonen The biology of vascular endothelial growth factors Cardiovasc Res, February 15, 2005; 65(3): 550 - 563. [Abstract] [Full Text] [PDF]

				D. J. Hicklin and L. M. Ellis Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis J. Clin. Oncol., February 10, 2005; 23(5): 1011 - 1027. [Abstract] [Full Text] [PDF]

				J. Sun and J. K. Liao Induction of Angiogenesis by Heat Shock Protein 90 Mediated by Protein Kinase Akt and Endothelial Nitric Oxide Synthase Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2238 - 2244. [Abstract] [Full Text] [PDF]

				L. G. Strauss, A. Dimitrakopoulou-Strauss, D. Koczan, L. Bernd, U. Haberkorn, V. Ewerbeck, and H.-J. Thiesen 18F-FDG Kinetics and Gene Expression in Giant Cell Tumors J. Nucl. Med., September 1, 2004; 45(9): 1528 - 1535. [Abstract] [Full Text] [PDF]

				C. L. Duvall, W. Robert Taylor, D. Weiss, and R. E. Guldberg Quantitative microcomputed tomography analysis of collateral vessel development after ischemic injury Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H302 - H310. [Abstract] [Full Text] [PDF]

				Y.-s. Yoon and D. W. Losordo All in the Family: VEGF-B Joins the Ranks of Proangiogenic Cytokines Circ. Res., July 25, 2003; 93(2): 87 - 90. [Full Text] [PDF]